UBS Group’s Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share KLR.WS Stock Holding History

UBS Group's KLR.WS Position: Q4 2023 in Review

UBS Group sold out of Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share (KLR.WS) in Q4 2023, closing a stake of 2,604 shares — an estimated $253 sold.

UBS Group first reported a position in KLR.WS in Q2 2020 and held it in 6 quarters. The position peaked at $4K in Q1 2021. 0 funds tracked by Wall St. Rank hold KLR.WS as of Q4 2023.

• UBS Group reported no remaining Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share position as of Q4 2023 after selling out during the quarter.
• UBS Group sold 2,604 Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share shares in Q4 2023, an estimated $253.
• UBS Group first reported a position in Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share in Q2 2020 and held it in 6 quarters.
• UBS Group's Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share position peaked at $4K in Q1 2021.
• 0 funds tracked by Wall St. Rank held Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.